http://hosted.ap.org/dynamic/stories/B/BIRD_FLU?SITE=ILKAN&SECTION=HOME&TEMPLATE=DEFAULTWASHINGTON (AP) -- Blood donated by four survivors of bird flu seems to harbor a potent protection against the deadly virus. Scientists have long suspected that culling immune-system molecules from survivors could provide a new therapy for the hard-to-treat H5N1 flu strain. Monday, an international team of researchers reported the first evidence, albeit from tests in mice, that it really may work.
If the research pans out, it could be possible to stockpile these antibodies, the immune system's search-and-destroy force, as an additional way to treat or even prevent H5N1 in case the worrisome flu strain ever mutates to spark a worldwide epidemic. snip
At Switzerland's Institute for Research in Biomedicine, Dr. Antonio Lanzavecchia created a way to cull antibody-producing cells from the blood and keep them churning out the molecules in laboratory dishes. snip
Mice given the non-H5N1 antibodies died. The H5N1-targeting antibodies protected mice, both when they were administered as a vaccine-like preventive or after infection. Importantly, they worked against both the same 2004 strain that the people had survived and against a different H5N1 strain that circulated in 2005.